PL2110141T3 - Środek ochronny dla nerwu siatkówki lub nerwu wzrokowego - Google Patents
Środek ochronny dla nerwu siatkówki lub nerwu wzrokowegoInfo
- Publication number
- PL2110141T3 PL2110141T3 PL08704120T PL08704120T PL2110141T3 PL 2110141 T3 PL2110141 T3 PL 2110141T3 PL 08704120 T PL08704120 T PL 08704120T PL 08704120 T PL08704120 T PL 08704120T PL 2110141 T3 PL2110141 T3 PL 2110141T3
- Authority
- PL
- Poland
- Prior art keywords
- nerve
- protective agent
- retinal
- optic
- optic nerve
- Prior art date
Links
- 210000005036 nerve Anatomy 0.000 title 1
- 210000001328 optic nerve Anatomy 0.000 title 1
- 239000003223 protective agent Substances 0.000 title 1
- 230000002207 retinal effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007021852 | 2007-01-31 | ||
EP08704120A EP2110141B1 (en) | 2007-01-31 | 2008-01-30 | Protective agent for retinal nerve or optic nerve |
PCT/JP2008/051338 WO2008093691A1 (ja) | 2007-01-31 | 2008-01-30 | 網膜神経又は視神経の保護剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2110141T3 true PL2110141T3 (pl) | 2013-09-30 |
Family
ID=39674000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08704120T PL2110141T3 (pl) | 2007-01-31 | 2008-01-30 | Środek ochronny dla nerwu siatkówki lub nerwu wzrokowego |
Country Status (11)
Country | Link |
---|---|
US (1) | US8536212B2 (pl) |
EP (2) | EP2110141B1 (pl) |
JP (1) | JP5363123B2 (pl) |
KR (1) | KR20090104014A (pl) |
CN (2) | CN103222974A (pl) |
AU (1) | AU2008210970B2 (pl) |
CA (1) | CA2673751C (pl) |
DK (1) | DK2110141T3 (pl) |
ES (1) | ES2409930T3 (pl) |
PL (1) | PL2110141T3 (pl) |
WO (1) | WO2008093691A1 (pl) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2139330B1 (en) * | 2007-03-23 | 2014-09-24 | The Board of Regents of The University of Texas System | Methods involving aldose reductase inhibitors |
KR20120129904A (ko) | 2010-01-14 | 2012-11-28 | 공립대학법인 나고야 시립대학 | 안내 혈관 신생 및/또는 안내 혈관 투과성 항진을 수반하는 질환의 예방 또는 치료를 위한 의약 |
CA2791360A1 (en) | 2010-04-28 | 2011-11-03 | Sanwa Kagaku Kenkyusho Co., Ltd. | A pharmaceutical for preventing or treating an inner ear disorder |
EP2671589A4 (en) * | 2011-02-02 | 2014-11-19 | Public Univ Corp Nagoya City Univ | MEDICINAL AGENT FOR THE PREVENTION OR TREATMENT OF DISEASES ASSOCIATED WITH INTRAOCULAR NEOVASCULARIZATION AND / OR INTRAOCULAR VASCULAR HYPERPERMABILITY |
KR101423631B1 (ko) * | 2012-08-17 | 2014-07-25 | 주식회사파마킹 | 에스-알릴엘-시스테인을 유효성분으로 포함하는 안질환 예방 또는 치료용 조성물 및 이를 포함하는 의약제제 |
US10034880B2 (en) | 2014-09-11 | 2018-07-31 | Sumitomo Dainippon Pharma Co., Ltd. | Ophthalmic suspension formulation |
KR102007640B1 (ko) | 2017-11-29 | 2019-08-07 | 퓨쳐메디신 주식회사 | 아데노신 유도체를 포함하는 망막 질환 또는 시신경 질환 예방 및 치료용 약학적 조성물 |
CN112004563A (zh) | 2018-02-01 | 2020-11-27 | 施菲姆德控股有限责任公司 | 血管内血泵以及使用和制造方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0258476B1 (en) * | 1986-09-02 | 1990-04-25 | Alcon Laboratories, Inc. | Aldose reductase inhibitors useful in glaucoma therapy |
US4609663A (en) * | 1984-09-11 | 1986-09-02 | Alcon Laboratories, Inc. | Aldose reductase inhibitors useful in glaucoma therapy |
JPS61200991A (ja) * | 1985-03-04 | 1986-09-05 | Sanwa Kagaku Kenkyusho:Kk | スピロ―3―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤 |
US5212196A (en) * | 1986-10-21 | 1993-05-18 | Alcon Laboratories, Inc. | Control of post-surgical intraocular pressure using clonidine derivatives |
US4966452A (en) * | 1989-04-27 | 1990-10-30 | Ocular Instruments, Inc. | Contact lens for laser surgery |
JP2997894B2 (ja) | 1990-11-07 | 2000-01-11 | 株式会社三和化学研究所 | 循環器系疾患の予防及び治療剤 |
JP3267698B2 (ja) | 1992-10-27 | 2002-03-18 | 株式会社三和化学研究所 | ヒダントイン誘導体及びその塩並びにこれらを有効成分とするメイラード反応阻害剤 |
JPH07242547A (ja) | 1994-03-02 | 1995-09-19 | Sanwa Kagaku Kenkyusho Co Ltd | 糖尿病性単純網膜症の進行阻止剤乃至治療剤 |
JP3603129B2 (ja) | 1994-12-28 | 2004-12-22 | 株式会社三和化学研究所 | 糖尿病性角膜症の治療剤 |
EP0719556B1 (en) | 1994-12-28 | 2000-10-25 | Sanwa Kagaku Kenkyusho Co., Ltd. | Use of (2S,4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazoline]-2-carboxamide for treating diabetic keratopathy |
US6127367A (en) * | 1996-02-29 | 2000-10-03 | Pfizer, Inc. | Method of reducing tissue damage associated with non-cardiac ischemia |
JPH11310538A (ja) * | 1998-02-24 | 1999-11-09 | Senju Pharmaceut Co Ltd | 白血球の粘着または凝集抑制剤 |
WO2001085183A2 (en) * | 2000-05-08 | 2001-11-15 | N.V. Nutricia | Preparation for the prevention and treatment of ocular disorders |
US6936043B2 (en) * | 2001-11-13 | 2005-08-30 | Minu, Llc | Method to treat age-related macular degeneration |
JP4014053B2 (ja) * | 2004-01-30 | 2007-11-28 | 株式会社三和化学研究所 | 糖尿病黄斑症の予防又は治療剤 |
CA2557392A1 (en) * | 2004-02-20 | 2005-09-01 | Sanwa Kagaku Kenkyusho Co., Ltd. | Preventive or therapeutic agents for severe diabetic retinopathy |
JP5022214B2 (ja) * | 2005-02-22 | 2012-09-12 | 株式会社三和化学研究所 | 虚血又は虚血再灌流によって起こる心機能障害若しくは心筋障害の予防又は治療剤 |
-
2008
- 2008-01-30 CN CN2013100775547A patent/CN103222974A/zh active Pending
- 2008-01-30 AU AU2008210970A patent/AU2008210970B2/en not_active Ceased
- 2008-01-30 PL PL08704120T patent/PL2110141T3/pl unknown
- 2008-01-30 JP JP2008556121A patent/JP5363123B2/ja not_active Expired - Fee Related
- 2008-01-30 DK DK08704120.8T patent/DK2110141T3/da active
- 2008-01-30 US US12/517,882 patent/US8536212B2/en not_active Expired - Fee Related
- 2008-01-30 CA CA2673751A patent/CA2673751C/en not_active Expired - Fee Related
- 2008-01-30 CN CNA2008800034513A patent/CN101594884A/zh active Pending
- 2008-01-30 EP EP08704120A patent/EP2110141B1/en not_active Not-in-force
- 2008-01-30 KR KR1020097013856A patent/KR20090104014A/ko active IP Right Grant
- 2008-01-30 WO PCT/JP2008/051338 patent/WO2008093691A1/ja active Application Filing
- 2008-01-30 ES ES08704120T patent/ES2409930T3/es active Active
- 2008-01-30 EP EP13155114.5A patent/EP2594267A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP2110141A1 (en) | 2009-10-21 |
EP2110141A4 (en) | 2011-01-19 |
EP2110141B1 (en) | 2013-04-03 |
CA2673751A1 (en) | 2008-08-07 |
CN101594884A (zh) | 2009-12-02 |
CA2673751C (en) | 2012-05-08 |
US20100216856A1 (en) | 2010-08-26 |
JP5363123B2 (ja) | 2013-12-11 |
WO2008093691A1 (ja) | 2008-08-07 |
US8536212B2 (en) | 2013-09-17 |
KR20090104014A (ko) | 2009-10-05 |
ES2409930T3 (es) | 2013-06-28 |
AU2008210970A1 (en) | 2008-08-07 |
JPWO2008093691A1 (ja) | 2010-05-20 |
DK2110141T3 (da) | 2013-06-17 |
CN103222974A (zh) | 2013-07-31 |
AU2008210970B2 (en) | 2012-11-29 |
EP2594267A1 (en) | 2013-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1205903A1 (en) | Binocular vision assessment and or therapy | |
HK1219912A1 (zh) | 眼放射外科 | |
HK1217005A1 (zh) | 能夠佩戴的防護裝置 | |
EP2170199A4 (en) | EYE THERAPY SYSTEM | |
EP2268340A4 (en) | OPTICAL NERVE IMPLANTS | |
EP2020970A4 (en) | TREATMENT OF THE EYE | |
PL2170232T3 (pl) | Laser odmładzający siatkówkę | |
HK1146900A1 (en) | Ophthalmic composition | |
EP2060264A4 (en) | AGENT FOR TREATING OCULAR DISEASES | |
EP2097054A4 (en) | SAFETY GOGGLES | |
PL2110141T3 (pl) | Środek ochronny dla nerwu siatkówki lub nerwu wzrokowego | |
GB0725124D0 (en) | Photic stimulation for eyes | |
GB0625670D0 (en) | Overpressure protector | |
GB0609919D0 (en) | Goggles | |
EP2036419A4 (en) | CASES | |
EP2251009A4 (en) | PROPHYLACTIC OR THERAPEUTIC FOR EYE DISEASE WITH ACCOMPANYING TELEPHONE DISEASE | |
GB2451429B (en) | Protective helmet | |
GB2452722B (en) | Vision shield | |
GB0610742D0 (en) | Protective apparatus | |
GB0703468D0 (en) | Safety goggles | |
PL379601A1 (pl) | Osłona oczu | |
PL381890A3 (pl) | Osłona oczu | |
GB0624461D0 (en) | Protection device for the eye | |
PL379005A1 (pl) | Okulary ochronne | |
PL385115A1 (pl) | Mikroimplanty do stosowania do oczu |